SCHEMBL2230287

SCHEMBL2230287

CC(O)C(O)CC(O)C(C)CO

nearest known ligand 0.40

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 2/20 0.40
TSHR P16473 1/20 0.35
LMNA P02545 1/20 0.32
L3MBTL1 Q9Y468 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4157868 0.82 ALDH1A1 (0.39) TDP1TSHRLMNA
SCHEMBL12938329 0.80 TSHR (0.44) TDP1TSHRLMNAL3MBTL1
SCHEMBL16074688 0.80 TDP1 (0.50) TDP1TSHRLMNAL3MBTL1
SCHEMBL43099 0.80 TSHR (0.44) TDP1TSHRLMNAL3MBTL1
SCHEMBL13754564 0.80 TDP1 (0.42) TDP1TSHRLMNAL3MBTL1
SCHEMBL13839699 0.78 LMNA (0.42) TDP1TSHRLMNAL3MBTL1
SCHEMBL1988036 0.76
SCHEMBL7882754 0.76
SCHEMBL2386043 0.76
SCHEMBL12264068 0.76

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2365957-B1 METHOD FOR MAKING CARBONATES AND ESTERS SABIC GLOBAL TECHNOLOGIES BV (NL) 2020-04-22 EP disclosed
EP-2365957-A2 METHOD FOR MAKING CARBONATES AND ESTERS SABIC Innovative Plastics IP B.V. (NL) 2011-09-21 EP disclosed
US-7977447-B2 Method for making carbonates and esters SABIC INNOVATIVE PLASTICS IP B.V. (NL) 2011-07-12 US disclosed
WO-2010059318-A2 METHOD FOR MAKING CARBONATES AND ESTERS SABIC INNOVATIVE PLASTICS IP B.V. (NL) 2010-05-27 WO disclosed
US-20100123097-A1 Method for Making Carbonates and Esters SABIC INNOVATIVE PLASTICS IP BV (NL) 2010-05-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100123097-A1 Method for Making Carbonates and Esters ADH1C, ADH1A, ADH5 TDP1 3786/4885TSHR 4410/4885LMNA 1364/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.